摘要：Extremely small-sized iron oxide nanoparticles(ESIONPs)with sizes less than 5 nm have shown great promise as T_(1)contrast agents for magnetic resonance imaging(MRI).However,their facile and scalable production with simultaneously endowed biocompatible surface chemistry remains difficult to be *** this study,by using the coprecipitation method implemented in a specially designed gas/liquid mixed phase fluidic reactor,polyglucose sorbitol carboxymethyether(PSC)coated ESIONPs were continuously synthesized with controllable particle sizes ranging from 1.8 to 4 *** the differently sized ESIONPs,the 3.7-nm ESIONPs exhibit the best performance as T_(1)MRI contrast agent,featuring a high r_(1) value of 4.11(mmol L^(−1))^(−1)s^(−1)and low r_(2)/r_(1) ratio of 7.90 under a clinical 3 T MR scanning,as well as the excellent T_(1)MRI contrast effect in not only water but also the cellular environment and blood ***,the ESIONPs possess long-term stability and good dispersity in aqueous dispersions,making them ideal candidates as safe and effective T_(1)-weighted MRI contrast agent for real clinical use.